There is a lot in the results that have been published.The...

There is a lot in the results that have been published.

The Cons:
Some more delays in Commercial Deal
Some more delays in FULL clinical results

The Pros:
VitroGro works
VitroGro works on the most difficult catergory of patients
Prof Harding (world authority in wound care) believes VitroGro is a game changer

What an amazing week I have had. Two of my heavy Biotech Investments (ACL & TIS) have come up with super news. Though the price action does not justify on either of these.

My take - it still is an amazing week because I hadnt imagined that I would still be able to buy these stocks after their announcements. But it is giving faithful (and knowledgable) investors yet another chance. I am a long termer in both the stocks mentioned above - and am adding on at these prices. Looks like end of this year will be great. Have gotten rid of some more mania stocks i have in Rare Earths, Coal, etc because the opportunity I am getting with these biotechs will be far greater than most can imagine. Remember I am talking medium to long term.


The above is my opinion only - DYOR. No advice given or intended.